Premium Nahrungsergänzungsmittel | artgerecht

Antifungal Agent – Mechanism, Uses and Side Effects

An antifungal agent is a medication used to treat fungal infections. It acts specifically against fungi and can be applied both locally and systemically.

Regular tips about health Regular tips about health

Things worth knowing about "Antifungal Agent"

An antifungal agent is a medication used to treat fungal infections. It acts specifically against fungi and can be applied both locally and systemically.

What is an Antifungal Agent?

An antifungal agent (also called an antimycotic) is a medication specifically designed to treat infections caused by fungi, known as mycoses. Fungal infections can affect the skin, mucous membranes, nails, or internal organs. Antifungal agents either kill fungi directly (fungicidal) or inhibit their growth (fungistatic).

Mechanism of Action

Most antifungal agents target the fungal cell membrane or cell wall, which differ significantly from human cells. This selectivity allows antifungals to act against fungi without causing the same degree of harm to human tissue.

Key Drug Classes and Their Mechanisms

Azoles (e.g., fluconazole, clotrimazole, itraconazole): Inhibit the synthesis of ergosterol, an essential component of the fungal cell membrane.
Polyenes (e.g., amphotericin B, nystatin): Bind directly to ergosterol, disrupting membrane integrity and causing cell death.
Echinocandins (e.g., caspofungin, micafungin): Inhibit the synthesis of beta-1,3-D-glucan, a key structural component of the fungal cell wall.
Allylamines (e.g., terbinafine): Inhibit ergosterol biosynthesis at an earlier step in the metabolic pathway.
Pyrimidines (e.g., flucytosine): Interfere with fungal DNA and RNA synthesis.

Indications

Antifungal agents are used for a wide range of fungal infections:

Skin fungal infections (dermatophytoses), such as athlete's foot (tinea pedis), nail fungus (onychomycosis), and ringworm (tinea corporis)
Mucosal infections, such as oral thrush or vaginal yeast infections (candidiasis) caused by Candida albicans
Systemic mycoses, such as invasive candidiasis, aspergillosis, or cryptococcosis, particularly in immunocompromised patients

Dosage Forms

Antifungal agents are available in various formulations depending on the type and severity of the infection:

Topical: Creams, ointments, powders, sprays, nail lacquers, vaginal suppositories, or oral gels – for superficial infections
Systemic: Tablets, capsules, or intravenous infusions – for deeper or more widespread infections

Dosage and Duration of Treatment

The appropriate dosage and treatment duration depend on the type of fungal infection, the affected body area, and the specific antifungal agent used. While superficial skin infections may resolve within a few weeks, nail infections or systemic mycoses may require several months of treatment. Stopping treatment early without medical advice can lead to relapse.

Side Effects

Like all medications, antifungal agents can cause side effects, which vary depending on the drug and the route of administration:

Topical application: Skin irritation, burning sensation, redness, or allergic reactions at the site of application
Systemic application: Nausea, vomiting, abdominal pain, headache, elevated liver enzyme levels (especially with azoles), and rarely serious liver damage
Amphotericin B (intravenous): Kidney damage, fever, and chills, commonly referred to as infusion-related reactions

Regular monitoring of liver and kidney function is recommended during systemic antifungal therapy.

Drug Interactions

Some antifungal agents, particularly azoles, can interact with other medications because they inhibit certain liver enzymes (cytochrome P450 enzymes). This can increase or decrease the effectiveness of other drugs taken concurrently. A doctor or pharmacist should always be consulted before starting antifungal therapy.

Resistance

As with antibiotics, antifungal resistance is a growing concern. Fungi can develop resistance to certain antifungal agents, rendering treatment ineffective. Proper use of antifungals, adherence to the recommended treatment duration, and targeted prescribing practices are essential to minimize the risk of resistance.

References

Pappas, P. G. et al. – Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 2016. PubMed PMID: 26679628.
World Health Organization (WHO) – Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. WHO, Geneva, 2022. Available at: https://www.who.int/publications/i/item/9789240060241
Rang, H. P. et al. – Rang and Dale's Pharmacology. 9th Edition. Elsevier, 2020.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.